Bryan Boone is a Global Program Director at Novartis. He possess expertise in clinical trials, clinical development, clinical research, gcp, ctms and 18 more skills. Colleagues describe him as "Bryan is a well respected professional. he us hard working, fast leaner and can succeed with minimal supervision. He us dedicated and will work hard to succeed and play the role as a team member or leader to achieve goals and success", "I had the honor of working with Bryan for a number of years at Merck. He is an invaluable resource to any team and often uses his experience and depth to think outside the box coming up with creative solutions with big impacts. He is a team player and seamlessly takes the lead when an issue arises- driving to a quick and decisive resolution. He diligently works to build strong relationships with his peers, key opinion leaders, direct reports etc. , which helps him work efficiently and fruitfully with all of his teams. Anyone who has had the opportunity to work with Bryan understands how valuable Bryan is to the team!", and "Recommending Bryan is effortless, let me tell you why; Bryan is an individual with integrity who demonstrates a polished and professional manner in all aspects of his role. He consistently showcases his commitment in providing high quality deliverables and outputs (in accordance with GCP/ICH) on the clinical trials he oversees; with both patient safety and data integrity being a paramount priority. When sharing challenges, proposals or operational overviews, he communicates with clarity and delivers messages clearly and directly. Bryan has an outstanding ability to remain calm under stress and negotiate under pressure - with skill and tact. Leveraging logic, he is able to consider alternative solutions, displays flexibility and creativity in thinking and makes good use of observations in decision making. His clinical trial subject matter expertise demonstrates a high level of competence and self confidence, all while remaining humble which is great complimentary skill set to have. Bryan fosters an incredible relationship with those in Clinical Quality Assurance who provide support to the trials within his therapeutic area; one of trust, collaboration, teamwork and partnering. It has been and continues to be a pleasure working with Bryan; he is a valued asset."